There are 2789 resources available
1075P - Regression tree analysis to identify factors associated with relapse-free survival (RFS) in patients with resected stage III BRAF V600E/K–mutant melanoma
Presenter: Caroline Robert
Session: ePoster Display
1076P - Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
Presenter: Mehmet Alpaslan Ozgun
Session: ePoster Display
1077P - Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
Presenter: Georgina Long
Session: ePoster Display
1078P - Real-world data on patients with melanoma brain metastases and outcome related to locoregional treatment modalities and systemic therapy
Presenter: Sidsel Pedersen
Session: ePoster Display
1080P - HORIZON: Final results from a 5-year ambispective study of 705 patients who initiated pembrolizumab for advanced melanoma in the French early access program
Presenter: Jean Jacques Grob
Session: ePoster Display
1019P - Selection of the optimal dose for ALX148, a CD47 blocker, using pharmacokinetic/pharmacodynamic modeling
Presenter: Oleg Demin Jr
Session: ePoster Display
1020P - MPT-0118 a clinical drug candidate to assess Treg reprogramming via MALT1 blockade
Presenter: Peter Keller
Session: ePoster Display
1021P - Long non-coding RNAs influence cancer immunotherapy efficacy through regulating T-cell infiltration and activity or tumor antigenicity
Presenter: Anlin Li
Session: ePoster Display
1022P - Frequency of PD1-negative and PD-1-positive ILCs in breast cancer patients depending on PD-L1 status
Presenter: Vladimir Alifanov
Session: ePoster Display